102.09
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos (NYSE:GKOS) CFO Alex Thurman Sells 625 Shares - MarketBeat
Glaukos SVP Thurman sells $61,968 in GKOS stock - Investing.com
Navratil, Glaukos corp officer, sells $101k in GKOS stock - Investing.com UK
Glaukos (NYSE: GKOS) CDO reports 1,031-share sale and tax withholding - Stock Titan
Glaukos (NYSE: GKOS) CFO sells 625 shares under 10b5-1 plan - Stock Titan
GLAUKOS (NYSE: GKOS) COO reports tax-withholding of 1,189 vested shares - Stock Titan
[Form 4] GLAUKOS Corp Insider Trading Activity - Stock Titan
Glaukos' Epioxa now commercially available in the US - Eyes On Eyecare
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care - BioSpace
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report? - Yahoo Finance
Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional - pharmiweb.com
Glaukos Corporation Announces Commercial Availability Of Epioxa HD / Epioxa For Keratoconus Treatment - marketscreener.com
Glaukos Launches Epioxa for Keratoconus Treatment - marketscreener.com
Glaukos (GKOS) Launches Epioxa HD for Keratoconus Treatment - GuruFocus
Glaukos announces commercial availability of Epioxa HD/Epioxa - TipRanks
(GKOS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Glaukos Corporation (NYSE:GKOS) Q4 2025 earnings call transcript - MSN
Glaukos (NYSE: GKOS) CDO reports tax-withholding of 1,074 shares - Stock Titan
Glaukos (GKOS) CEO Burns reports 5,212-share tax withholding and large trust holdings - Stock Titan
[144] GLAUKOS Corp SEC Filing - Stock Titan
Glaukos Corporation $GKOS Shares Sold by Holocene Advisors LP - MarketBeat
Cinctive Capital Management LP Makes New Investment in Glaukos Corporation $GKOS - MarketBeat
Alliancebernstein L.P. Has $141.37 Million Holdings in Glaukos Corporation $GKOS - MarketBeat
SpyGlass Valued at $900M After IPO - Orange County Business Journal
Glaukos Corporation $GKOS Shares Purchased by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Sells 109,170 Shares of Glaukos Corporation $GKOS - MarketBeat
Truist Securities maintains Glaukos (GKOS) buy recommendation - MSN
Braidwell LP Acquires 176,750 Shares of Glaukos Corporation $GKOS - MarketBeat
GKOS Stock Falls -20% In 9-day Spree On Earnings Shock - Trefis
Integral Health Asset Management LLC Acquires 50,000 Shares of Glaukos Corporation $GKOS - MarketBeat
Capital International Investors Buys 264,971 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation (GKOS) Stock Price Today | Live Chart & News - Traders Union
Citi Sticks to Its Buy Rating for Glaukos (GKOS) - The Globe and Mail
Atika Capital Management LLC Has $17.32 Million Position in Glaukos Corporation $GKOS - MarketBeat
Here's Why You Should Retain Glaukos Stock in Your Portfolio - MSN
Glaukos Corporation (GKOS) Stock Price History & Data - Traders Union
Zacks Research Has Negative Outlook of Glaukos Q1 Earnings - MarketBeat
Zacks Research Weighs in on Glaukos FY2028 Earnings - MarketBeat
Glaukos (NYSE: GKOS) CEO has 1,098 shares withheld for taxes - Stock Titan
Canaloplasty Market Is Going to Boom |• Glaukos Corporation • Aquesys Inc - openPR.com
Citigroup Inc. Sells 34,689 Shares of Glaukos Corporation $GKOS - MarketBeat
(GKOS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
GKOS Earnings History & Surprises | EPS & Revenue Results | GLAUKOS CORP (NYSE:GKOS) - ChartMill
Performance Recap: Is Glaukos Corporation affected by consumer sentimentJuly 2025 News Drivers & AI Forecasted Stock Moves - baoquankhu1.vn
TD Asset Management Inc Takes Position in Glaukos Corporation $GKOS - MarketBeat
Glaucoma Surgery Device Market Is Going to Boom | Glaukos Corporation • Santen Pharmaceutical • Carl Zeiss AG - openPR.com
Glaukos Corporation $GKOS Shares Purchased by AustralianSuper Pty Ltd - MarketBeat
GKOS Should I Buy - Intellectia AI
Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS - simplywall.st
Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
William Blair Investment Management LLC Has $89.20 Million Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update - TipRanks
Glaukos : Investor Presentation March 2026 - marketscreener.com
Glaukos unveils March 2026 investor presentation highlighting iDose TR approval, Epioxa launch and 2026 $610M sales guide - TradingView
Glaukos (GKOS) furnishes March 2026 Investor Presentation for stakeholders - Stock Titan
DNB Asset Management AS Purchases 16,267 Shares of Glaukos Corporation $GKOS - MarketBeat
GKOS SEC FilingsGlaukos Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Glaukos Refines Glaucoma Implant Delivery With New Inserter Study - TipRanks
Primecap Management Co. CA Grows Stake in Glaukos Corporation $GKOS - MarketBeat
Fox Run Management L.L.C. Purchases Shares of 12,308 Glaukos Corporation $GKOS - MarketBeat
Glaukos : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Glaukos (NYSE: GKOS) CEO has 4,059 shares withheld to cover taxes - Stock Titan
Glaukos (NYSE: GKOS) CDO reports 396-share tax-withholding disposition - Stock Titan
GLAUKOS (GKOS) COO’s RSU vesting triggers 1,057-share tax withholding - Stock Titan
Glaukos Corporation $GKOS Shares Acquired by Westfield Capital Management Co. LP - MarketBeat
자본화:
|
볼륨(24시간):